These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Disseminated leishmaniasis caused by Leishmania tropica in HIV-positive patients in the Islamic Republic of Iran. Jafari S; Hajiabdolbaghi M; Mohebali M; Hajjaran H; Hashemian H East Mediterr Health J; 2010 Mar; 16(3):340-3. PubMed ID: 20795452 [No Abstract] [Full Text] [Related]
6. Case Report: Progressive Dysphonia and Dysphagia due to Laryngeal Leishmaniasis. Renard L; Lemaignen A; Desoubeaux G; Bakhos D Am J Trop Med Hyg; 2021 Jun; 105(2):458-460. PubMed ID: 34125697 [TBL] [Abstract][Full Text] [Related]
8. Visceral leishmaniasis: rapid response to AmBisome treatment. Smith OP; Hann IM; Cox H; Novelli V Arch Dis Child; 1995 Aug; 73(2):157-9. PubMed ID: 7574862 [TBL] [Abstract][Full Text] [Related]
9. Mucosal leishmaniasis in a Sudanese patient. Abbas K; Musatafa MA; Abass S; Kheir MM; Mukhtar M; Elamin EM; Elhassan AM Am J Trop Med Hyg; 2009 Jun; 80(6):935-8. PubMed ID: 19478252 [TBL] [Abstract][Full Text] [Related]
10. Diagnosis and management of oral leishmaniasis--case series and literature review. Nadler C; Enk CD; Leon GT; Samuni Y; Maly A; Czerninski R J Oral Maxillofac Surg; 2014 May; 72(5):927-34. PubMed ID: 24480757 [TBL] [Abstract][Full Text] [Related]
11. [Laryngeal leishmaniasis]. Díaz Sastre MA; Padilla Parrado M; Morales Puebla JM; Jiménez Antolín JA; Caro García MA; Chacón Martínez J; Menéndez Loras LM; Orradre Romeo JL An Otorrinolaringol Ibero Am; 2007; 34(1):17-25. PubMed ID: 17405455 [TBL] [Abstract][Full Text] [Related]
12. Leishmaniasis in patients with chronic renal failure: a diagnostic and therapeutic challenge for the clinician. Maggi P; Gaudiano V; Valente M; Latorraca A; Cavaliere RL; Marroni M; Larocca AM; Stagni G; Lopez T; Pastore G J Nephrol; 2004; 17(2):296-301. PubMed ID: 15293532 [TBL] [Abstract][Full Text] [Related]
15. Cutaneous leishmaniasis with boggy induration and simultaneous mucosal disease. Mings S; Beck JC; Davidson C; Ondo AL; Shanler SD; Berman J Am J Trop Med Hyg; 2009 Jan; 80(1):3-5. PubMed ID: 19141829 [TBL] [Abstract][Full Text] [Related]
16. Post-kala-azar dermal leishmaniasis (PKDL) developing after treatment of visceral leishmaniasis with amphotericin B and miltefosine. Kumar D; Ramesh V; Verma S; Ramam M; Salotra P Ann Trop Med Parasitol; 2009 Dec; 103(8):727-30. PubMed ID: 20030997 [No Abstract] [Full Text] [Related]
17. Leishmaniasis due to L. infantum presenting as macrocheilitis and responding to liposomal amphotericin B. Rongioletti F; Cannata GE; Parodi A Eur J Dermatol; 2009; 19(3):281-2. PubMed ID: 19286487 [No Abstract] [Full Text] [Related]
18. A severe case of visceral leishmaniasis and liposomal amphotericin B treatment failure in an immunosuppressed patient 15 years after exposure. Eichenberger A; Buechi AE; Neumayr A; Hatz C; Rauch A; Huguenot M; Diamantis-Karamitopoulou E; Staehelin C BMC Infect Dis; 2017 Jan; 17(1):81. PubMed ID: 28095796 [TBL] [Abstract][Full Text] [Related]
20. Visceral leishmaniasis in an infant following a holiday trip to Spain. Trück J; Rampton C; Kelly SJ; Kelly D BMJ Case Rep; 2015 Apr; 2015():. PubMed ID: 25920739 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]